Abstract
In Ireland, over 3,000 patients are diagnosed with breast cancer annually, and 1 in 9 Irish women will be diagnosed with breast cancer in their lifetime. There is evidence that female breast cancer survivors are more likely to die of cardiovascular disease than their age-matched counterparts. This protocol describes a prospective, single arm, pilot feasibility study implementing a dedicated Cardio-Oncology assessment and surveillance pathway for patients receiving multimodal breast cancer treatment. It incorporates novel biomarker and radiomic surveillance and monitoring approaches for cancer-therapy related cardiac dysfunction into routine care for breast cancer patients undergoing adjuvant systemic chemotherapy.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT05921279
Funding Statement
Irish Cancer Society, The National Breast Cancer Research Institute and Science Foundation Ireland each fund elements of this study. 1.0 FTE Cardio-Oncology Nurse has been funded through Irish Cancer Society, NBCRI and SFI (Prof. Wijns). Funds are managed through a grant portal through University of Galway Research office. Funding will cover staff costs and running costs for the project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Galway University Hospital research ethics board
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Non-standard Abbreviations and Acronyms
- CTRCD
- Cancer Treatment Related Cardiac Dysfunction
- ESC
- European Society of Cardiology
- QOL
- Quality of life
- ECG
- Electrocardiogram
- PIL
- Patient information leaflet
- ICF
- Informed consent form
- TTE
- Transthoracic echocardiography
- HFA-ICOS
- Heart Failure Association – International Cardio-Oncology Society
- EORTC
- The European Organisation for Research and Treatment of Cancer
- IPAQ-SF
- International Physical Activity Questionnaire Short Form
- KCCQ
- Kansas City Cardiomyopathy Questionnaire
- PSS-10
- Perceived Stress Scale
- STAI
- State Trait Anxiety Inventory
- HSE
- Health Service Executive
- GDPR
- General Data Protection Regulation
- ISF
- Investigator site file
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.